기사

Ceramique Clinic Gangnam and Myeongdong Designated as Clinical Partner Clinics and Key Collaboration Hubs
Partnership to Advance Clinical Protocols and Expand Medical Education and Academic Collaboration

[Edaily, Reporter Lee Jung-hoon] Regenerative medicine company PRODIZEN announced on the 28th that it has signed a strategic Memorandum of Understanding (MOU) with The Day Labs to expand the clinical application of autologous platelet-rich plasma (PRP)-related products and technologies, develop and refine field-based clinical protocols, and promote education for healthcare professionals and academic collaboration.

PRODIZEN CEO Sim Soo-ja (left) and The Day Labs CEO Lee Jong-jin at the MOU signing ceremony. (Photo courtesy of PRODIZEN)

Through this agreement, the two companies will move beyond a conventional product supply relationship to establish a collaborative ecosystem in which a technology developer and clinical practice work together to build real-world experience and incorporate those insights back into products, education, and clinical application frameworks. To support the systematic use of PRP based on clinical judgment and individual patient needs, the companies will continuously gather feedback from healthcare professionals and jointly identify areas for improvement arising from real-world use.

Under the agreement, Ceramique Clinic’s Gangnam and Myeongdong branches will be designated as “PRODIZEN Clinical Partner Clinics.” The two clinics will serve as key collaboration hubs, sharing feedback from healthcare professionals, insights on usability, educational needs, and areas for improvement in PRP application protocols.

The roles of each company are clearly defined. PRODIZEN will provide PRP-related products and technical materials while offering training and technical support for healthcare professionals. The Day Labs will collect feedback from clinical settings through close communication with partner medical institutions and will be responsible for operational support and identifying new areas for collaboration.

The two companies will also regularly review their clinical application experience to progressively enhance product usage guidelines, educational content, and application protocols. Based on accumulated cases and ongoing discussions, they plan to expand the scope of their collaboration through seminars, workshops, and academic exchanges.

Through this collaborative framework, medical institutions will receive consistent training and technical support, while PRODIZEN will be able to rapidly incorporate clinical needs into its products and services. Leveraging its expertise in hospital operations and its network of healthcare professionals, The Day Labs will further strengthen its role as a collaborative platform connecting technology with clinical practice.

Following an evaluation of the collaboration at the Gangnam and Myeongdong branches, the two companies plan to gradually expand their network of partner medical institutions. Future initiatives will include establishing regular training programs for healthcare professionals, refining application guidelines for specific clinical fields, and developing academic content.

Both companies share the view that the successful and consistent application of PRP in clinical practice requires not only reliable product performance, but also professional education, standardized operating procedures, and continuous post-implementation support. They intend to use this agreement as a starting point for developing a long-term, clinically driven collaboration framework.

A PRODIZEN representative said, “This partnership is particularly meaningful because it establishes a practical collaboration framework that closely connects real-world clinical experience with PRODIZEN’s PRP technology and expertise. We will continuously incorporate feedback gathered from the Gangnam and Myeongdong clinics into our products, education, and protocols to establish a more systematic environment for PRP application.”

The representative added, “We will expand our collaborative network with medical institutions and healthcare professionals and strengthen clinically focused educational and academic activities. Through these efforts, we aim to enhance the clinical value of PRP technology while contributing to the competitiveness of Korea’s regenerative medicine sector.”

PRODIZEN is a regenerative medicine company that develops products and technologies related to PRP and other autologous blood-derived regenerative medicine solutions. The company continues to build an integrated system of products, education, and technical support designed to address the needs of clinical practice.

The Day Labs supports hospital operations and clinical collaboration through its network of medical institutions and healthcare professionals. Together with Ceramique Clinic’s Gangnam and Myeongdong branches and other partners, the company is working to enhance the professional quality of medical services and strengthen operational competitiveness.